This topic contains a solution. Click here to go to the answer

Author Question: A premenopausal woman has ER-positive breast cancer, and her prescriber has ordered tamoxifen ... (Read 11 times)

acc299

  • Hero Member
  • *****
  • Posts: 569
A premenopausal woman has ER-positive breast cancer, and her prescriber has ordered tamoxifen (Nolvadex). She asks the nurse if anastrozole (Arimedex) would work better for her. What will the nurse tell her?
 
  a. Anastrozole is more likely to cause hot flushes than tamoxifen.
  b. Anastrozole is more likely to promote endometrial carcinoma.
  c. Cancer recurrence is higher with anastrozole.
  d. Until she is postmenopausal, anastrozole will not be effective.

Question 2

A 45-year-old patient with a family history of breast cancer is considering using tamoxifen (Nolvadex) for cancer prevention.
 
  The nurse performs a health history and learns that the woman had a child when she was 35 years old, that she has not had a hysterectomy, and that she experienced DVT when she was pregnant. What will the nurse tell the patient?
  a. Because of her family risk and late childbearing, this drug is a good choice for her.
  b. Her history of DVT outweighs any possible benefits she may have with this drug.
  c. Since she has not had a hysterectomy, the risk of endometrial cancer is too great.
  d. When she turns 50 years old, this drug will carry fewer risks for her.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amy.lauersdorf90

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

ANS: D
Anastrozole is used to treat ER-positive breast cancer in postmenopausal women. Because it does not block estrogen production in the ovaries, it is not effective in premenopausal women. It may cause hot flushes but is less likely to do so than tamoxifen. It is devoid of all estrogenic activity and does not promote endometrial cancer

Answer to Question 2

ANS: B
Tamoxifen is a good choice for women between the ages of 40 and 49 years as a cancer preventive, except for women at risk for DVT. Her family risk and late childbearing are indications for using tamoxifen, but only in women without increased risk of DVT. The risk of endometrial cancer increases with age and, without the risk of DVT, would not be a contraindication in a woman her age. Her risks of DVT do not change with age.




acc299

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


T4T

  • Member
  • Posts: 348
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

For a complete list of videos, visit our video library